Direct selective laser trabeculoplasty: A retrospective study

被引:0
作者
Fossati, Giovanni [1 ,2 ]
Trevisi, Marco [2 ]
Sarodia, Usman [1 ]
Malick, Huzaifa [1 ]
Abdou, Hamza [1 ]
Sodeinde, Modupe [1 ]
Romano, Mario R. [2 ,3 ]
Osman, Lina [1 ]
机构
[1] Univ Hosp Leicester NHS Trust, Ophthalmol Dept, Leicester, England
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Dept Ophthalmol, Eye Unit Humanitas Gavazzeni Castelli, Bergamo, Italy
关键词
Laser surgery < GLAUCOMA; GLAUCOMA; glaucoma medical therapies < GLAUCOMA; aqueous humor dynamics < GLAUCOMA; biochemistry/physiology of aqueous < GLAUCOMA; EFFICACY;
D O I
10.1177/11206721241301935
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the effectiveness and safety profiles of Direct Selective Laser Trabeculoplasty (DSLT). Materials and Methods: Retrospective study of 15 eyes of 10 patients diagnosed with open angle glaucoma (OAG) or ocular hypertension (OHT) who underwent DSLT in June 2023 at University Hospitals of Leicester, UK. We defined success as IOP reduced >= 20% from baseline with no additional medications needed or as a decrease in the number of anti-glaucoma medications while maintaining target IOP. We also considered secondary outcomes such as final BCVA and final number of anti-glaucoma medications. Results: At the fourth month visit, success was reached in 11 eyes (73.3%). We registered 4 failures (26.7%). Mean IOP at baseline was 22.7 +/- 4.4 mmHg and was reduced to 18.7 +/- 4.2 mmHg (p = 0.008). The absolute mean reduction of IOP in the group of eyes that maintained unchanged the number of medications was 5.4 +/- 2.7 mmHg, as baseline IOP was 21.4 +/- 4.3 mmHg, and final IOP was 15.9 +/- 2.3 mmHg, with a 25.7% reduction (p = 0.003). Mean BCVA remained unchanged (0.1 +/- 0.1 logMAR, p = 1.00). No significant adverse events requiring surgical or clinical intervention were observed. Conclusion: DSLT showed profiles of effectiveness and safety comparable with those of SLT in the literature and consistent with the results obtained in previous studies on DSLT itself. DSLT may represent a valid alternative to traditional SLT.
引用
收藏
页数:7
相关论文
共 19 条
  • [1] Excimer laser trabeculotomy vs 180° selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trial
    Babighian, S.
    Caretti, L.
    Tavolato, M.
    Cian, R.
    Galan, A.
    [J]. EYE, 2010, 24 (04) : 632 - 638
  • [2] Diagnostic and surgical techniques - Selective laser trabeculoplasty
    Barkana, Yaniv
    Belkin, Michael
    [J]. SURVEY OF OPHTHALMOLOGY, 2007, 52 (06) : 634 - 654
  • [3] Direct selective laser trabeculoplasty in open angle glaucoma study design: a multicentre, randomised, controlled, investigator-masked trial (GLAUrious)
    Congdon, Nathan
    Azuara-Blanco, Augusto
    Solberg, Yoram
    Traverso, Carlo E.
    Iester, Michele
    Cutolo, Carlo Alberto
    Bagnis, Alessandro
    Aung, Tin
    Fudemberg, Scott J.
    Lindstrom, Richard
    Samuelson, Thomas
    Singh, Kuldev
    Blumenthal, Eytan Z.
    Gazzard, Gus
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (01) : 62 - 65
  • [4] Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial
    Damji, K. F.
    Bovell, A. M.
    Hodge, W. G.
    Rock, W.
    Shah, K.
    Buhrmann, R.
    Pan, Y. I.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (12) : 1490 - 1494
  • [5] Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial
    Garg, Anurag
    Vickerstaff, Victoria
    Nathwani, Neil
    Garway-Heath, David
    Konstantakopoulou, Evgenia
    Ambler, Gareth
    Bunce, Catey
    Wormald, Richard
    Barton, Keith
    Gazzard, Gus
    [J]. OPHTHALMOLOGY, 2020, 127 (04) : 467 - 476
  • [6] Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
    Garg, Anurag
    Vickerstaff, Victoria
    Nathwani, Neil
    Garway-Heath, David
    Konstantakopoulou, Evgenia
    Ambler, Gareth
    Bunce, Catey
    Wormald, Richard
    Barton, Keith
    Gazzard, Gus
    [J]. OPHTHALMOLOGY, 2019, 126 (09) : 1238 - 1248
  • [7] Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
    Gazzard, Gus
    Konstantakopoulou, Evgenia
    Garway-Heath, David
    Garg, Anurag
    Vickerstaff, Victoria
    Hunter, Rachael
    Ambler, Gareth
    Bunce, Catey
    Wormald, Richard
    Nathwani, Neil
    Barton, Keith
    Rubin, Gary
    Buszewicz, Marta
    Bourne, Rupert
    Broadway, David
    Bunce, Catey
    Buszewicz, Marta
    Davis, Amanda
    Jayaram, Hari
    Jiang, Yuzhen
    Lim, Sheng
    Liput, Joanna
    Manners, Timothy
    Morris, Stephen
    Strouthidis, Nicholas
    Wilson, Sarah
    Wormald, Richard
    Zhu, Haogang
    [J]. LANCET, 2019, 393 (10180) : 1505 - 1516
  • [8] Transscleral Selective Laser Trabeculoplasty Without a Gonioscopy Lens
    Geffen, Noa
    Ofir, Shay
    Belkin, Avner
    Segev, Fani
    Barkana, Yaniv
    Messas, Audrey Kaplan
    Assia, Ehud I.
    Belkin, Michael
    [J]. JOURNAL OF GLAUCOMA, 2017, 26 (03) : 201 - 207
  • [9] Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial
    Goldenfeld, Mordechai
    Belkin, Michael
    Dobkin-Bekman, Masha
    Sacks, Zachary
    Meirovitch, Sharon Blum
    Geffen, Noa
    Leshno, Ari
    Skaat, Alon
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (03): : 1 - 11
  • [10] Morphologic and Cellular Changes Induced by Selective Laser Trabeculoplasty
    Gupta, Meenakashi
    Heo, Jae Young
    Gong, Haiyan
    Cha, Elliot
    Latina, Mark
    Rhee, Douglas J.
    [J]. CLINICAL OPHTHALMOLOGY, 2022, 16 : 1383 - 1390